SEC Comment Letter 0000000000-24-002537 to Passage BIO, Inc. (PASG) (CIK 0001787297) (PASG)
Passage BIO, Inc. (PASG) (CIK 0001787297)
Date: March 7, 2024 · CIK: 0001787297 · Accession: 0000000000-24-002537
AI Filing Summary & Sentiment
File numbers found in text: 333-277632
Letter
United States securities and exchange commission logo March 7, 2024 William Chou, M.D. Chief Executive Officer Passage Bio, Inc. One Commerce Square 2005 Market Street, 39th Floor Philadelphia, PA 19103 Re:Passage Bio, Inc. Registration Statement on Form S-3 Filed March 4, 2024 File No. 333-277632 Dear William Chou: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan Mitteness, Esq.
Show Raw Text
United States securities and exchange commission logo
March 7, 2024
William Chou, M.D.
Chief Executive Officer
Passage Bio, Inc.
One Commerce Square
2005 Market Street, 39th Floor
Philadelphia, PA 19103
Re:Passage Bio, Inc.
Registration Statement on Form S-3
Filed March 4, 2024
File No. 333-277632
Dear William Chou:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ryan Mitteness, Esq.